UK clinical trial sector must address prolonged timelines, say experts
Experts highlighted the need to address a gap in UK regulatory timelines compared to international standards.
Business & Regulation
Pharma, patient advocates clash over Inflation Reduction Act
Joe Biden’s global corporation tax deal: A prediction on what’s next
Regulatory roundup: BMS’s T lymphocyte immunotherapy tripped by lung cancer trial termination
Regulatory roundup: Ology, MaxCyte make moves in women’s cancer with divergent approval chances
Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite
